159 related articles for article (PubMed ID: 11564179)
1. T-cell-immunity-based inhibitory effects of orally administered herbal medicine juzen-taiho-to on the growth of primarily developed melanocytic tumors in RET-transgenic mice.
Dai Y; Kato M; Takeda K; Kawamoto Y; Akhand AA; Hossain K; Suzuki H; Nakashima I
J Invest Dermatol; 2001 Sep; 117(3):694-701. PubMed ID: 11564179
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of a traditional Chinese medicine, Juzen-taiho-to, on progressive growth of weakly malignant clone cells derived from murine fibrosarcoma.
Ohnishi Y; Fujii H; Kimura F; Mishima T; Murata J; Tazawa K; Fujimaki M; Okada F; Hosokawa M; Saiki I
Jpn J Cancer Res; 1996 Oct; 87(10):1039-44. PubMed ID: 8957061
[TBL] [Abstract][Full Text] [Related]
3. Oral administration of a Kampo (Japanese herbal) medicine Juzen-taiho-to inhibits liver metastasis of colon 26-L5 carcinoma cells.
Ohnishi Y; Fujii H; Hayakawa Y; Sakukawa R; Yamaura T; Sakamoto T; Tsukada K; Fujimaki M; Nunome S; Komatsu Y; Saiki I
Jpn J Cancer Res; 1998 Feb; 89(2):206-13. PubMed ID: 9548449
[TBL] [Abstract][Full Text] [Related]
4. Linkage between melanocytic tumor development and early burst of Ret protein expression for tolerance induction in metallothionein-I/ret transgenic mouse lines.
Kato M; Liu W; Akhand AA; Dai Y; Ohbayashi M; Tuzuki T; Suzuki H; Isobe K; Takahashi M; Nakashima I
Oncogene; 1999 Jan; 18(3):837-42. PubMed ID: 9989837
[TBL] [Abstract][Full Text] [Related]
5. Expression of the anti-metastatic effect induced by Juzen-taiho-to is based on the content of Shimotsu-to constituents.
Onishi Y; Yamaura T; Tauchi K; Sakamoto T; Tsukada K; Nunome S; Komatsu Y; Saiki I
Biol Pharm Bull; 1998 Jul; 21(7):761-5. PubMed ID: 9703264
[TBL] [Abstract][Full Text] [Related]
6. Effect of interferon-alpha A/D in combination with the Japanese and Chinese traditional herbal medicine juzen-taiho-to on lung metastasis of murine renal cell carcinoma.
Muraishi Y; Mitani N; Yamaura T; Fuse H; Saiki I
Anticancer Res; 2000; 20(5A):2931-7. PubMed ID: 11062703
[TBL] [Abstract][Full Text] [Related]
7. Establishment and characterization of a malignant melanocytic tumor cell line expressing the ret oncogene.
Taniguchi M; Iwamoto T; Nakashima I; Nakayama A; Ohbayashi M; Matsuyama M; Takahashi M
Oncogene; 1992 Aug; 7(8):1491-6. PubMed ID: 1630812
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling of lens tumors, liver and spleen in α-crystallin/SV40 T antigen transgenic mice treated with Juzen-taiho-to.
Zheng HC; Noguchi A; Kikuchi K; Ando T; Nakamura T; Takano Y
Mol Med Rep; 2014 Feb; 9(2):547-52. PubMed ID: 24337676
[TBL] [Abstract][Full Text] [Related]
9. c-Kit-targeting immunotherapy for hereditary melanoma in a mouse model.
Kato M; Takeda K; Kawamoto Y; Tsuzuki T; Hossain K; Tamakoshi A; Kunisada T; Kambayashi Y; Ogino K; Suzuki H; Takahashi M; Nakashima I
Cancer Res; 2004 Feb; 64(3):801-6. PubMed ID: 14871802
[TBL] [Abstract][Full Text] [Related]
10. Effect of artesunate on immune cells in ret-transgenic mouse melanoma model.
Ramacher M; Umansky V; Efferth T
Anticancer Drugs; 2009 Nov; 20(10):910-7. PubMed ID: 19745721
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Juzen-taiho-to against vincristine-induced toxicity in dogs.
Shinohara Y; Nishino Y; Yamanaka M; Ohmori K; Elbadawy M; Usui T; Sasaki K
J Vet Med Sci; 2019 Dec; 81(12):1810-1816. PubMed ID: 31645506
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of MMP-9 and TIMP-2 expression in malignant melanoma developed in metallothionein/RET transgenic mice.
Asai M; Kato M; Asai N; Iwashita T; Murakami H; Kawai K; Nakashima I; Takahashi M
Jpn J Cancer Res; 1999 Jan; 90(1):86-92. PubMed ID: 10076570
[TBL] [Abstract][Full Text] [Related]
13. The herbal medicine Sho-saiko-to inhibits growth and metastasis of malignant melanoma primarily developed in ret-transgenic mice.
Kato M; Liu W; Yi H; Asai N; Hayakawa A; Kozaki K; Takahashi M; Nakashima I
J Invest Dermatol; 1998 Oct; 111(4):640-4. PubMed ID: 9764846
[TBL] [Abstract][Full Text] [Related]
14. Preventive effects of Juzen-taiho-to on N-methyl-N-nitrosourea and estradiol-17beta-induced endometrial carcinogenesis in mice.
Niwa K; Hashimoto M; Morishita S; Lian Z; Tagami K; Mori H; Tamaya T
Carcinogenesis; 2001 Apr; 22(4):587-91. PubMed ID: 11285193
[TBL] [Abstract][Full Text] [Related]
15. Improvement of cisplatin toxicity and lethality by juzen-taiho-to in mice.
Sugiyama K; Ueda H; Ichio Y; Yokota M
Biol Pharm Bull; 1995 Jan; 18(1):53-8. PubMed ID: 7735251
[TBL] [Abstract][Full Text] [Related]
16. Possible anti-oxidative effects of long-term administration of Juzen-taiho-to in dogs.
Shinohara Y; Oyama A; Usui T; Sasaki K
J Vet Med Sci; 2019 Nov; 81(11):1616-1620. PubMed ID: 31588073
[TBL] [Abstract][Full Text] [Related]
17. Mapping of melanoma modifier loci in RET transgenic mice.
Dragani TA; Peissel B; Zanesi N; Aloisi A; Dai Y; Kato M; Suzuki H; Nakashima I
Jpn J Cancer Res; 2000 Nov; 91(11):1142-7. PubMed ID: 11092979
[TBL] [Abstract][Full Text] [Related]
18. [Potentiation of the therapeutic effect of chemotherapy and hyperthermia on experimental tumor and reduction of immunotoxicity of mitomycin C by juzen-taiho-toh, a Chinese herbal medicine].
Komiyama K; Zhibo Y; Umezawa I
Gan To Kagaku Ryoho; 1989 Feb; 16(2):251-7. PubMed ID: 2493224
[TBL] [Abstract][Full Text] [Related]
19. [The effect of herbal medicines on the immunodeficient animals by injecting cancer chemotherapeutic agent-special reference to age related recovery of the function].
Li AL; Komatsu Y; Ono Y; Nakatani F; Nakashima K; Yamaguchi N
Kansenshogaku Zasshi; 1996 Jul; 70(7):717-26. PubMed ID: 8797307
[TBL] [Abstract][Full Text] [Related]
20. Preventive effect of Juzen-taiho-to on endometrial carcinogenesis in mice is based on Shimotsu-to constituent.
Tagami K; Niwa K; Lian Z; Gao J; Mori H; Tamaya T
Biol Pharm Bull; 2004 Feb; 27(2):156-61. PubMed ID: 14758024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
